ライフサイエンスコーパス: parvovirus B19

1 hrovirus and is closely related to the human parvovirus B19.

2 a highly efficient systemic dissemination of parvovirus B19.

3 s and allow beta1 integrin-mediated entry of parvovirus B19.

4 een reported to be the cellular receptor for parvovirus B19.

5 reported to be the cell surface receptor for parvovirus B19, a number of nonerythroid cells, which ex

6 ere detected in EMBs from 37 (39%) patients; parvovirus B19, adenovirus, and Epstein-Barr virus (EBV)

7 The structures of infectious human parvovirus B19 and empty wild-type particles were determ

8 recent studies investigating the presence of parvovirus B19 and herpesviruses in temporal arteries wi

9 d confirmatory study, livers were tested for parvovirus B19 and its variant erythroviruses, V9 and A6

10 wo human parvoviruses, namely the pathogenic parvovirus B19 and the nonpathogenic adeno-associated vi

11 Infections with human parvoviruses B19 and recently discovered human bocavirus

12 and therapeutic utility of the knowledge of parvovirus B19 as the likely etiologic link between the

13 antibodies to nonstructural protein NS-1 in parvovirus B19-associated arthritis have been detected.

14 hat of Aleutian mink disease virus and human parvovirus B19, autonomous members of the genus, despite

15 Parvovirus B19 (B19 virus) can persist in multiple tissu

16 Persistent infections with human parvovirus B19 (B19) associated with debilitating chroni

17 Parvovirus B19 (B19) can cause acute arthritis, and occa

18 Parvovirus B19 (B19) can cause chronic anemia due to per

19 Parvovirus B19 (B19) DNA was detected by dot blot hybrid

20 Human parvovirus B19 (B19) IgG was studied retrospectively in

21 We evaluated the prevalence of persistent parvovirus B19 (B19) infection and associated anemia in

22 We analyzed the response to parvovirus B19 (B19), a ubiquitous and clinically signif

23 ive Finnish casualties from World War II for parvovirus B19 (B19V) DNA, and found a remarkable preval

24 The pathogenic parvovirus B19 (B19V) has an extreme tropism for human e

25 Intrauterine parvovirus B19 (B19V) infection can be asymptomatic or m

26 Human parvovirus B19 (B19V) infection has a unique tropism to

27 Parvovirus B19 (B19V) infection is highly restricted to

28 Human parvovirus B19 (B19V) infection is restricted to erythro

29 Accurate diagnosis of parvovirus B19 (B19V) infection requires the differentia

30 Human parvovirus B19 (B19V) infection shows a strong erythroid

31 Human parvovirus B19 (B19V) is a common pathogen in microvascu

32 Parvovirus B19 (B19V) is a member of the family Parvovir

33 Human parvovirus B19 (B19V) is a member of the genus Erythrovi

34 Parvovirus B19 (B19V) is pathogenic for humans and has a

35 Human parvovirus B19 (B19V) is the only human pathogenic parvo

36 ng of the precursor mRNA (pre-mRNA) of human parvovirus B19 (B19V) plays a key role in posttranscript

37 Alternative processing of parvovirus B19 (B19V) pre-mRNA is critical to generating

38 more conformational antigens to detect human parvovirus B19 (B19V)-specific immunoglobulin M (IgM) or

39 an erythroleukemia cells (K562), which allow parvovirus B19 binding but not entry.

40 e documented that P antigen is necessary for parvovirus B19 binding but not sufficient for virus entr

41 igen, but not alpha 5 beta 1 integrins, bind parvovirus B19 but do not allow viral entry.

42 Recent studies have shown that parvovirus B19 can cause acute arthritis and occasionall

43 Infection with human parvovirus B19 causes fifth disease, acute and chronic r

44 The closely related erythrovirus, parvovirus B19, causes anemia in susceptible humans and

45 rus, Toxoplasma gondii, rubella virus, human parvovirus B19, Chlamydia trachomatis, or human papillom

46 ial fibroblasts were treated with or without parvovirus B19-containing human sera for 7 days.

47 Incubation with parvovirus B19-containing serum induced an invasive phen

48 ns (such as syphillis, varicella-zoster, and parvovirus B19), cytomegalovirus, and herpes simplex vir

49 oinfection with HBV, and 1 case each of HBV, parvovirus B19, cytomegalovirus, and human herpesvirus 7

50 regnant Ghanaian women were tested for human parvovirus B19 DNA and B19-specific antibodies.

51 isco, Calif.) for real-time PCR detection of parvovirus B19 DNA by retesting 71 specimens previously

52 Parvovirus B19 DNA has been detected in studies in the s

53 significant difference in the prevalence of parvovirus B19 DNA in livers from patients with FH or HA

54 In the first study, parvovirus B19 DNA was detected by nested polymerase cha

55 antigen is necessary but not sufficient for parvovirus B19 entry into cells, and (iv) parvovirus B19

56 562 cells become adherent and permissive for parvovirus B19 entry, which is mediated by alpha 5 beta

57 knowledge of the crystal structure of human parvovirus B19 (genus Erythrovirus).

58 Parvovirus B19 has been implicated in some cases of acut

59 Parvovirus B19 has been proposed as an etiologic agent o

60 Parvovirus B19 has been proposed as the etiological agen

61 gene polymorphisms have been associated with parvovirus B19, hepatitis C virus, HIV-1/AIDS infection,

62 ure red cell aplasia (PRCA) related to human parvovirus B19 (HPV-B19) infection.

63 er rash-causing infections, such as measles, parvovirus B19, human herpesvirus 6, and enteroviruses i

64 Parvovirus B19 immunoglobulin M positivity was associate

65 irst-trimester serum samples were tested for parvovirus B19 immunoglobulin M positivity.

66 We studied the prevalence of parvovirus B19 in liver-tissue samples from patients wit

67 tential involvement of, cytomegalovirus, and parvovirus B19 in SSc pathogenesis.

68 her examine the role of the host response to parvovirus B19 in the development of symptoms and conseq

69 mens from individuals with lupus (n = 16) or parvovirus B19 infection (n = 6) or specimens containing

70 Because parvovirus B19 infection during pregnancy has been assoc

71 In conclusion, acute parvovirus B19 infection during the first trimester of p

72 Our knowledge of the consequences of parvovirus B19 infection has broadened to include the va

73 Parvovirus B19 infection in adults is often associated w

74 oglobulin (IVIg) in the treatment of chronic parvovirus B19 infection, this therapy can cure some of

75 e development of symptoms during acute human parvovirus B19 infection, we compared human leukocyte an

76 ch express P antigen, are not permissive for parvovirus B19 infection.

77 er of reports of myocarditis associated with parvovirus B19 infection.

78 pure red cell aplasia resulting from chronic parvovirus B19 infection.

79 measured in the sera of patients with acute parvovirus B19 infections (n = 12), in those with other

80 n HLA-A*2402-positive individuals with acute parvovirus B19 infections made vigorous CD8-positive cyt

81 e cellular coreceptor for efficient entry of parvovirus B19 into human cells.

82 Replication of the pathogenic human parvovirus B19 is restricted to erythroid progenitor cel

83 Human parvovirus B19 is the cause of several distinct clinical

84 Human parvovirus B19 is the only parvovirus known to be a huma

85 We evaluated the artus RealArt Parvovirus B19 LC PCR reagent (artus biotech USA, San Fr

86 tive ANLL samples bound both shiga toxin and parvovirus B19 on HPTLC immunostaining.

87 P<.0001) alleles was significantly higher in parvovirus B19 patients than in control subjects.

88 ly 0.1% of fetal losses were attributable to parvovirus B19 positivity, a proportion which could incr

89 ncluding transplant recipients infected with parvovirus B19 (PV B19).

90 Expression of globotetraosylceramide, the parvovirus B19 receptor, on myeloblasts may also explain

91 Parvovirus B19-seronegative adults (n=24) received eithe

92 Human parvovirus B19 shows remarkable tropism for human erythr

93 capsids, or virus-like particles (VLPs), of parvovirus B19 that carry dengue 2-specific epitopes wer

94 Parvovirus B19, the only known human pathogenic parvovir

95 Like human parvovirus B19, this virus has a predilection for erythr

96 of cell types and is involved in binding of parvovirus B19 to human cells, (ii) the level of P antig

97 ide direct evidence regarding the ability of parvovirus B19 to induce invasive properties in normal h

98 everse-transcriptase PCR for the presence of parvovirus B19 transcripts as a marker of viral replicat

99 (HBV) or hepatitis C virus (HCV) infection; parvovirus B19 transcripts were not detected.

100 biopsy, explant, or autopsy was analyzed for parvovirus B19 using primers designed to amplify a 699-b

101 To test whether parvovirus B19 utilizes a cell surface coreceptor for en

102 A recombinant human parvovirus B19 vaccine (MEDI-491; MedImmune) composed of

103 or parvovirus B19 entry into cells, and (iv) parvovirus B19 vectors can be used to transduce HUVEC an

104 ave described the development of recombinant parvovirus B19 vectors with which high-efficiency, eryth

105 an enzyme immunoassay that detects the human parvovirus B19 virus (B19V) immunoglobulin M (IgM) or Ig

106 pectrum of the acute polyarthritis caused by parvovirus B19 was further delineated and was shown to i

107 rospective Southern analyses to detect human parvovirus B19 was performed in the 27 patients for whom

108 Human erythrovirus genotype 1 (formerly parvovirus B19) was prevalent in the United Kingdom, Mal

109 parvovirus (SPV), an Erythrovirus similar to Parvovirus B19, was investigated.